Cellosaurus A549-ACE2 (CVCL_C0Q5)
| Cell line name | A549-ACE2 |
|---|---|
| Synonyms | A549-Ace2 |
| Accession | CVCL_C0Q5 |
| Resource Identification Initiative | To cite this cell line use: A549-ACE2 (RRID:CVCL_C0Q5) |
| Comments | Group: SARS-CoV-2 research cell line. Population: Caucasian. Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2. Omics: Transcriptomics; RNAseq. Derived from site: In situ; Lung; UBERON=UBERON_0002048. |
| Sequence variations |
|
| Disease | Lung adenocarcinoma (NCIt: C3512) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_0023 (A-549) |
| Sex of cell | Male |
| Age at sampling | 58Y |
| Category | Cancer cell line |
| Publications | PubMed=33208793; DOI=10.1038/s41467-020-19619-7; PMCID=PMC7676268 |
| Cross-references | |
| Cell line databases/resources | cancercelllines; CVCL_C0Q5 |
| Encyclopedic resources | Wikidata; Q112927063 |
| Gene expression databases | GEO; GSM5224710
GEO; GSM5224711 GEO; GSM5224712 |
| Proteomic databases | PRIDE; PXD019645
PRIDE; PXD023418 |
| Entry history | |
| Entry creation | 23-Jun-2022 |
| Last entry update | 10-Apr-2025 |
| Version number | 8 |